Winston Medical Supply Co., Ltd. (TPEX:6817)
48.85
-0.15 (-0.31%)
Aug 19, 2026, 1:25 PM CST
Winston Medical Supply Revenue
Winston Medical Supply had revenue of 341.25M TWD in the half year ending December 31, 2025, a decrease of -7.67%. This brings the company's revenue in the last twelve months to 632.80M, down -12.64% year-over-year. In the year 2025, Winston Medical Supply had annual revenue of 700.07M with 0.72% growth.
Revenue (ttm)
632.80M
Revenue Growth
-12.64%
P/S Ratio
1.57
Revenue / Employee
3.52M
Employees
180
Market Cap
992.68M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 700.07M | 5.00M | 0.72% |
| Dec 31, 2024 | 695.08M | -14.00M | -1.97% |
| Dec 31, 2023 | 709.07M | 102.56M | 16.91% |
| Dec 31, 2022 | 606.52M | 69.99M | 13.05% |
| Dec 31, 2021 | 536.53M | 31.41M | 6.22% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| TSH Biopharm Corporation | 1.40B |
| Prince Pharmaceutical | 1.22B |
| Excelsior Biopharma | 936.92M |
| Anxo Pharmaceutical | 878.88M |
| DV Biomed | 795.19M |
| GeneFerm Biotechnology | 664.94M |
| General Biologicals | 260.23M |
| Bioray Biotech | 222.73M |